MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson’s disease diagnosis

M. Rossi, C. Terroba Chambi, A. Bril, P. Millar Vernetti, D. Cerquetti, A. Cammarota, M. Merello (Buenos Aires, Argentina)

Meeting: 2016 International Congress

Abstract Number: 348

Keywords: Levodopa(L-dopa), Olfactory dysfunction

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinson's disease: Non-motor symptoms

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the diagnostic value of combined acute levodopa challenge and olfactory testing to predict PD diagnosis.

Background: Acute levodopa challenge can be used to predict sustained long-term dopaminergic response and support a possible diagnosis of Parkinson’s disease (PD). Olfactory testing is often used in clinical practice, as hyposmia is a nonmotor feature of PD that can precede motor symptoms by several years. The combination of both to predict sustained long-term dopaminergic response was not previously evaluated.

Methods: We conducted a retrospective review of medical records from patients with recent onset of parkinsonism that were submitted to acute levodopa challenge for clinical prediction of sustained long-term dopaminergic response and that underwent olfactory testing with Sniffin’ Sticks Test (SST). Patients with at least two years of follow-up were included. When a minimal 24% improvement was not reached, acute levodopa challenge was rated negative. Sensitivity (Se), specificity (Sp), positive and negative predictive values (PPV; NPV) and likelihood ratios (LR+; LR-) together with diagnostic effectiveness (Accuracy), and Youden’s index (‘J’) were calculated for the acute levodopa challenge in combination with three olfaction variables: hyposmia by SST total score (HypTot), hyposmia by identification subscore (HypIdent) and anosmia by SST total score (AnTot).

Results: Two hundred and ten patients (157 PD and 53 non-PD) were included: 113 patients were rated as positive on acute levodopa challenge, which was 70.1% sensitive and 94.3% specific for predict sustained long-term dopaminergic response, showing PPV=97.3%; NPV=51.5%; LR+=12.3; LR-=0.32; Accuracy=76.2% and J=0.64. Combination of acute levodopa challenge and olfactory testing enhanced sensitivity for all three olfactory variables (HypTot=90.4%, HypIdent=90.4%, AnTot=83.4%) and also improved NPV (HypTot=72.2%, HypIdent=71.2%, AnTot=62.3%). Diagnostic power as evaluated by Accuracy (HypTot=86.2%, HypIdent=85.2%, AnTot=82.9%) and ‘J’ (HypTot=0.64, HypIdent=0.60, AnTot=0.65) showed improvements in the combination performance.

Conclusions: The combination of acute levodopa challenge and hyposmia by SST total score, enhances the sensitivity and accuracy for predicting sustained long-term dopaminergic response as a major ancillary criteria for PD diagnosis.

To cite this abstract in AMA style:

M. Rossi, C. Terroba Chambi, A. Bril, P. Millar Vernetti, D. Cerquetti, A. Cammarota, M. Merello. Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson’s disease diagnosis [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/diagnostic-value-of-combined-acute-levodopa-challenge-and-olfactory-testing-to-predict-parkinsons-disease-diagnosis/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/diagnostic-value-of-combined-acute-levodopa-challenge-and-olfactory-testing-to-predict-parkinsons-disease-diagnosis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley